SPONSORS & EXHIBITORS

Science. Engineering. Technology. Combined the right way, they enable us to solve difficult problems and achieve our mission of improving health through the advancement of our clients’ best new medicines.Bend Research is the leader in drug delivery...

Valneva is a European biotech company focusing on vaccines, striving to become a leader in its field.

hVIVO is a world-leading life sciences company dedicated to the study of the Human Challenge Model (HCM), an extensive scientific analysis of how viruses and other illnesses behave in the human body. The Human Challenge Model enables pharmaceutical...

PRA Health Sciences delivers innovative drug development solutions that improve patients’ lives. Our people work tirelessly for clients, offering exceptional experience across all phases, therapeutic areas and a broad spectrum of services. With...

SGS Life Science Services is a leading contract service organization providing clinical research, analytical development, biologics characterization, biosafety, and quality control testing. Delivering comprehensive solutions for...

FUJIFILM Diosynth Biotechnologies (FDB) is a world leader in biologics contract services with over thirty years of combined experience in development to manufacturing of recombinant proteins, vaccines, monoclonal antibodies and gene therapies...

Ichor is dedicated to the clinical application and commercialization of its TriGrid™ electroporation technology for the delivery of nucleic acid based biologics to treat a broad spectrum of disease indications including cancer, chronic viral...

ICON plc is a global provider of drug development solutions and services to the pharmaceutical, biotechnology and medical device industries. The company specialises in the strategic development, management and analysis of programs that support...

Batavia Biosciences accelerates the transition of biopharmaceutical product candidates from discovery to the clinic with improved success and lower cost. Batavia Biosciences is extensive experienced in developing and improving biopharmaceutical...

Immunomic Therapeutics, Inc. (ITI) is a privately held clinical stage biotechnology company headquartered in Lancaster, PA with lab facilities in Rockville, MD. ITI is developing next generation vaccines based on the patented LAMP Technology. Our...

VacciXcell was established by the 2nd generation founders of the ESCO group of companies, a world leader in laboratory, medical and pharmaceutical equipment solutions since 1978. Following the same guiding principles of the ESCO founders, VacciXcell ...

Julius Clinical is an Academic Research Organization with a CRO infrastructure. We combine academic leadership, a large global network, and industry standard clinical operations to perform trials that have a major impact on the practice of...

Inovio is revolutionizing the fight against cancer and infectious diseases. Our immunotherapies uniquely activate best-in-class immune responses to prevent and treat disease, including HPV-caused pre-cancers and cancers, prostate...

ClinicalRM is a full service Contract Research Organization (CRO) that provides a full range of Medical/Regulatory and Clinical Services for early to late stage clinical research, clinical trial support, and product development for...

Paragon Bioservices is a contract research and manufacturing organization (CMO) whose focus is the production of bacterial and viral vaccines. We are a preferred vendor for multiple government agencies, pharmaceutical and biotechnology companies. ...

IDT Biologika  GmbH  –  Biopharmaceutical Contract Development & Manufacturing ServicesIDT operates one of Europe’s premiere integrated biological and pharmaceutical development and manufacturing facilities. With decades of experience developing ...

VaxCorps is a network of highly experienced, geographically diverse clinical research centers specializing in the conduct of vaccine trials in healthy adult, elderly, and pediatric populations. VaxCorps clinical sites have successfully conducted...

Located in Princeton, N.J., Advaxis, Inc. is a clinical-stage biotechnology company developing multiple cancer immunotherapies based on its proprietary Lm Technology™. The Lm Technology™, using bioengineered live attenuated Listeria monocytogenes...

Bavarian Nordic is an international biotechnology company developing and manufacturing novel cancer immunotherapies and vaccines for infectious diseases. Lead product candidates are PROSTVAC®, an immunotherapy product candidate for advanced prostate ...

Covance Inc., the drug development business of Laboratory Corporation of America® Holdings (LabCorp®) headquartered in Princeton, New Jersey, is the world's most comprehensive drug development company, dedicated to advancing healthcare and...

FluGen was founded in response to the need for significant improvement in vaccine efficacy, most notably with influenza vaccines.     Current influenza vaccines work less than half the time in most years even in healthy adults.  FluGen’s response to ...

Harrisvaccines is an emerging leader in the development and commercialization of herd-specific, rapid response, and efficient vaccines.  Our vaccines target newer and/or difficult-to-control disease outbreaks that threaten today’s food-producing...

Kineta, Inc. is a biotechnology company focused on the development of new, targeted immune modulating drugs. We are developing five drug and vaccine programs focused on autoimmune diseases, antivirals and chronic pain. Kineta’s corporate strategy is ...

Liquidia Technologies, founded in 2004, is a privately held biotechnology company located in Research Triangle Park, North Carolina.  By leveraging precise fabrication techniques of the semiconductor industry, Liquidia has become the only company in ...

Mabtech is a Swedish biotech company producing high quality reagents for measuring antigen-specific immune responses. We are world leaders in advancing the ELISpot and FluoroSpot methods, which are important tools for monitoring vaccine-induced T-...

Madison Vaccines Incorporated (MVI) is developing two different DNA vaccines to treat prostate cancer patients throughout critical stages of their disease.  MVI-816 is a PAP DNA vaccine progressing in a multi-site Phase 2 clinical trial in...

Mucosis B.V. is a clinical stage biotechnology company developing innovative mucosal vaccines that can be applied needle-free via the nose or mouth. Mucosis’s lead product candidate is SynGEM®, an intranasal vaccine to prevent respiratory syncytial...

Northwest Biotherapeutics is focused on developing personalized, non-toxic, cost-effective immunotherapy products to treat cancers more effectively than current treatments.  We have a broad platform technology for DCVax® dendritic cell-based...

Platinum Research Network (PRN) is a collaboration of established, independently owned research sites. PRN sites are geographically, demographically and therapeutically diverse and consist of 5 companies with 13 locations across 7 states. The PRN...

Scancell is developing novel immunotherapies for the treatment of cancer based on its ImmunoBody® and Moditope® technology platforms.  Scancell’s first ImmunoBody®, SCIB1 is being developed for the treatment of melanoma and is being evaluated in a...

Vaxart is a privately held, clinical-stage company developing tablet vaccines. The company’s proprietary delivery platform is suitable to deliver any recombinant vaccine in oral form and allows rapid development to address emerging threats. Vaxart...

VBI Vaccines Inc. (Nasdaq: VBIV) is a biopharmaceutical company developing novel technologies that seek to expand vaccine protection in large underserved markets. VBI’s eVLP vaccine platform allows for the design of enveloped (“e”) virus-like...